BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25652107)

  • 1. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
    Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants.
    de Jong WU; de Jong PA; Vliegenthart R; Isgum I; Lammers JW; Oudkerk M; van der Aalst C; de Koning HJ; Mohamed Hoesein FA
    J Bone Miner Res; 2014 Oct; 29(10):2224-9. PubMed ID: 24715549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of COPD as Predictors of Lung Cancer.
    Carr LL; Jacobson S; Lynch DA; Foreman MG; Flenaugh EL; Hersh CP; Sciurba FC; Wilson DO; Sieren JC; Mulhall P; Kim V; Kinsey CM; Bowler RP
    Chest; 2018 Jun; 153(6):1326-1335. PubMed ID: 29452098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Cancer Screening in Patients with COPD-A Case Report.
    Amirahmadi R; Kumar AJ; Cowan M; Deepak J
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT.
    Tang LYW; Coxson HO; Lam S; Leipsic J; Tam RC; Sin DD
    Lancet Digit Health; 2020 May; 2(5):e259-e267. PubMed ID: 33328058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and Challenges of Lung Cancer Screening in Older Adults.
    Fabrikant MS; Wisnivesky JP; Marron T; Taioli E; Veluswamy RR
    Clin Ther; 2018 Apr; 40(4):526-534. PubMed ID: 29573852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.
    Pinsky PF; Kramer BS
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26483244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    Criss SD; Sheehan DF; Palazzo L; Kong CY
    PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.